Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-01-05 @ 6:39 PM
Study NCT ID:
NCT02339532
Status:
COMPLETED
Last Update Posted:
2024-11-08
First Post:
2014-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
Sponsor:
UNICANCER
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-14
First Submit QC Date:
None
Study First Post Date:
2015-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-06
Last Update Post Date:
2024-11-08
Last Update Post Date Type:
ACTUAL